Dr. Terence Lin, MD

Dr. Lin practices at Palo Alto Medical Foundation-Fremont Center in Fremont, California.

Dr. Lin's NPI, 1952385403, was assigned on November 29, 2005. Dr. Lin graduated from UC Davis School of Medicine in 2003. Dr. Lin holds California license A88330.

Dr. Lin's primary practice is Palo Alto Medical Foundation-Fremont Center, at 3200 Kearney Street, Fremont, CA 94538. The practice phone is (510) 498-2812.

Dr. Lin's primary practice is Palo Alto Medical Foundation-Fremont Center in Fremont, California. Dr. Lin is also affiliated with Washington Health. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Lin to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Lin's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Lin is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Lin is licensed in California.

Dmand AI lists angioplasty, cardiac catheterization, pacemaker or defibrillator implantation and pacemaker replacement among the conditions Dr. Lin treats.

CMS data shows 2,839 Medicare services from Dr. Lin across 28 procedure codes in 2024, for 1,423 Medicare patients. Medicare paid $179,729 for them.

CMS counts 1,423 Medicare patients who saw Dr. Lin in 2024. The largest group is 75 to 84, with 540 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 62, with 44% women.

In 2024, Dr. Lin wrote 3,127 Medicare Part D claims for 376 patients. 89% of them were for generic drugs. CMS names the drug for 2,899 of them, across 40 drugs with 11 or more claims each, at $491,603 in total drug cost. In 2023, CMS named 2,933 claims across 37 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth. CMS counts 25 procedures of coronary angioplasty and stenting by Dr. Lin, more than 58% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Lin. Dr. Lin's most frequent co-authors are Ramesh C. Bansal, MD, Kenneth Jutzy, MD and Ramdas G. Pai, MD.

CMS Open Payments shows 54 general payments to Dr. Lin from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Medtronic, Inc. paid the most, $3,589.

Dmand AI lists 2 awards for Dr. Lin, most recently CMS Stage 1 EHR in 2013.

Dr. Lin graduated from UC Davis School of Medicine in 2003. Dr. Lin is a member of ACC.

Dr. Lin is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.